Surgery in haemophilia patients with inhibitors, with special emphasis on orthopaedics: Madrid experience

Haemophilia

Volumn 16, Issue 102, 2010, Pages 84-88

  Rodriguez Merchan, E C ^a   Jimenez Yuste, V ^a   Gomez Cardero, P ^a   Alvarez Roman, M ^a   Martin Salces, M ^a   Rodriguez de la rua, A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Haemophilia; Inhibitors; Orthopaedics; Surgery

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; YTTRIUM 90;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLEEDING; CHEMOPROPHYLAXIS; CHILD; FRACTURE FIXATION; HEMOPHILIA; HEMOSTASIS; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOSYNOVECTOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; SYNOVECTOMY; TOTAL KNEE REPLACEMENT;

ADOLESCENT; ADULT; BLOOD COAGULATION FACTORS; BLOOD LOSS, SURGICAL; CHILD; DRUG ADMINISTRATION SCHEDULE; FACTOR VIIA; FEMALE; FOLLOW-UP STUDIES; HEMOPHILIA A; HEMOPHILIA B; HUMANS; JOINT DISEASES; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE CARE; RECOMBINANT PROTEINS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953219503     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02223.x     Document Type: Article

References (16)

1. Brackmann HH, Oldenburg J, Schwaab R. Immune tolerance for the treatment of factor VIII inhibitors. Twenty years " Bonn Protocol" Vox Sang 1996, 70(Suppl. 1):30-5.
2. Abildgaard CF, Penner JA, Watson-Williams EJ. Anti-inhibitor coagulant complex (Autoplex) for treatment of factor inhibitors in hemophilia. Blood 1980, 56:978-84.
3. Hilgartner MW, Knatterud GL. The use of Factor Eight Inhibitor By-passing Activity (Feiba Immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors. Blood 1983, 61:36-40.
4. Hilgartner M, Aledort L, Andes A, Gill J. Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients. Transfusion 1990, 30:626-30.
5. Hedner U, Glazer S, Pinkel K. Successful use of recombinant factor VIIa in a patient with severe haemophilia A during synovectomy. Lancet 1988, 2:1193.
6. Hedner U, Glazer S, Falch J. Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders. Transfus Med Rev 1993, 7:78-83.
7. Hedner U, Ingerslev J. Clinical use of recombinant FVIIa (rFVIIa). Transfus Sci 1998, 19:163-76.
8. Roberts HR. Clinical experience with activated factor VII: focus on safety. Blood Coagul Fibrinolysis 1998, 9(Suppl. 1):S115-8.
9. White GC, Taylor RE, Blatt PM, Roberts HR. Treatment with a high titer anti-factor VIII antibody by continuous factor VIII administration: report of a case. Blood 1983, 62:141-5.
10. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. Arch Intern Med 1989, 149:1381-5.
11. Bona RD, Pasquale DN, Kalish RI, Witter BA. Porcine factor VIII and plasmapheresis in the management of hemophilic patients with inhibitors. Am J Hematol 1986, 21:201-7.
12. Lozier JN, Santagostino E, Kasper CK, Teitel JM, Hay CRM. Use of porcine factor VIII for surgical procedures in haemophilia A patients with inhibitors. Semin Hematol 1993, 30(Suppl. 1):10-21.
13. Heisel MA, Gomperts ED, Gordon McComb J, Hilgartner M. Use of activated prothrombin complex concentrate over multiple surgical episodes in a hemophilic child with an inhibitor. J Pediatr 1983, 102:951-4.
14. Rodriguez-Merchan EC, Wiedel JD, Wallny T. Elective orthopaedic surgery for inhibitors patients. Haemophilia 2003, 9:625-31.
15. Rodriguez-Merchan EC, Quintana M, Jimenez-Yuste V, Hernandez-Navarro F. Orthopaedic surgery for inhibitor patients: a series of 27 procedures (25 patients). Haemophilia 2007, 13:613-9.
16. Quintana-Molina M, Martinez-Bahamonde F, Gonzalez-Garcia E. Surgery in haemophilia patient with inhibitor: 20 years of experience. Haemophilia 2004, 10(Suppl. 2):30-40.